Importance of sex and gender factors for COVID-19 infection and hospitalisation: a sex-stratified analysis using machine learning in UK Biobank data.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 05 2022
Historique:
entrez: 18 5 2022
pubmed: 19 5 2022
medline: 21 5 2022
Statut: epublish

Résumé

To examine sex and gender roles in COVID-19 test positivity and hospitalisation in sex-stratified predictive models using machine learning. Cross-sectional study. UK Biobank prospective cohort. Participants tested between 16 March 2020 and 18 May 2020 were analysed. The endpoints of the study were COVID-19 test positivity and hospitalisation. Forty-two individuals' demographics, psychosocial factors and comorbidities were used as likely determinants of outcomes. Gradient boosting machine was used for building prediction models. Of 4510 individuals tested (51.2% female, mean age=68.5±8.9 years), 29.4% tested positive. Males were more likely to be positive than females (31.6% vs 27.3%, p=0.001). In females, living in more deprived areas, lower income, increased low-density lipoprotein (LDL) to high-density lipoprotein (HDL) ratio, working night shifts and living with a greater number of family members were associated with a higher likelihood of COVID-19 positive test. While in males, greater body mass index and LDL to HDL ratio were the factors associated with a positive test. Older age and adverse cardiometabolic characteristics were the most prominent variables associated with hospitalisation of test-positive patients in both overall and sex-stratified models. High-risk jobs, crowded living arrangements and living in deprived areas were associated with increased COVID-19 infection in females, while high-risk cardiometabolic characteristics were more influential in males. Gender-related factors have a greater impact on females; hence, they should be considered in identifying priority groups for COVID-19 infection vaccination campaigns.

Identifiants

pubmed: 35584867
pii: bmjopen-2021-050450
doi: 10.1136/bmjopen-2021-050450
pmc: PMC9118360
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e050450

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom

Investigateurs

Alexandra Kautzky-Willer (A)
Karolina Kublickiene (K)
Maria Trinidad Herrero (MT)

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Microb Genom. 2020 Jul;6(7):
pubmed: 32553051
Brain Behav Immun. 2020 Jul;87:184-187
pubmed: 32454138
Neuroimaging Clin N Am. 2020 Nov;30(4):433-445
pubmed: 33038994
BMC Bioinformatics. 2010 Feb 27;11:110
pubmed: 20187966
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
Occup Environ Med. 2020 Dec 9;:
pubmed: 33298533
PLoS One. 2021 Apr 1;16(4):e0248602
pubmed: 33793566
Proc Int Conf Mach Learn. 2012 Dec 1;2012:349
pubmed: 24350304
Brain Behav Immun. 2020 Aug;88:44-49
pubmed: 32497776
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Prim Care Diabetes. 2020 Oct;14(5):566-567
pubmed: 32493608
CMAJ. 2020 Sep 8;192(36):E1041-E1045
pubmed: 32900766
PLoS One. 2020 Nov 17;15(11):e0241264
pubmed: 33201886
Neuroimaging Clin N Am. 2020 Nov;30(4):e17-e32
pubmed: 33039003
BMC Med. 2020 May 29;18(1):160
pubmed: 32466757
Nat Rev Immunol. 2020 Jul;20(7):442-447
pubmed: 32528136
EClinicalMedicine. 2020 Dec;29:100652
pubmed: 33283178
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1315-1316
pubmed: 32755828
Wellcome Open Res. 2020 May 6;5:88
pubmed: 32613083
Expert Syst Appl. 2020 Dec 1;160:113661
pubmed: 32834556
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230
pubmed: 32687551
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
JMIR Public Health Surveill. 2021 Sep 30;7(9):e29544
pubmed: 34591027
Int J Equity Health. 2020 Jul 6;19(1):114
pubmed: 32631328
Mayo Clin Proc. 2020 Oct;95(10):2189-2203
pubmed: 33012349
Int J Equity Health. 2009 May 06;8:14
pubmed: 19419579
J Clin Epidemiol. 2021 Jan;129:191-197
pubmed: 32980428

Auteurs

Zahra Azizi (Z)

Centre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Québec, Canada.

Yumika Shiba (Y)

Department of Biology, McGill University, Montreal, Québec, Canada.

Pouria Alipour (P)

Centre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Québec, Canada.
Faculty of Medicine and Health Sciences, McGill University, Montreal, Québec, Canada.

Farhad Maleki (F)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology, McGill University Health Centre, Montreal, Québec, Canada.

Valeria Raparelli (V)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.

Colleen Norris (C)

Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
Heart and Stroke Strategic Clinical Networks, Alberta Health Services, Edmonton, Alberta, Canada.

Reza Forghani (R)

Augmented Intelligence & Precision Health Laboratory (AIPHL), Department of Radiology, McGill University Health Centre, Montreal, Québec, Canada.

Louise Pilote (L)

Centre for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Québec, Canada louise.pilote@mcgill.ca kelemam@ehealthinformation.ca.
Faculty of Medicine and Health Sciences, McGill University, Montreal, Québec, Canada.
Divisions of Clinical Epidemiology and General Internal Medicine, McGill University Health Centre Research Institute, Montreal, Quebec, Canada.

Khaled El Emam (K)

Electronic Health Information Laboratory, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada louise.pilote@mcgill.ca kelemam@ehealthinformation.ca.
School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH